Creating hope through breakthrough new cancer medicines
Quiet Therapeutics is a cancer drug discovery company engaged in the discovery and development of novel immuno-oncology and targeted anti-cancer medicines based on the combination of DNA, RNA, or small molecule drugs with our proprietary technology.
Welcome to our Quiet revolution
Quiet’s mission is to create revolutionary cancer therapies by unlocking the maximum potential of anti-cancer and immuno-modulatory agents in the tumor microenvironment while minimizing systemic effects.
We are developing a diverse set of DNA, RNA, and small molecule anti-cancer therapeutics.
Enabling this platform is our proprietary GAGomer technology, which provides for targeted delivery to tumor cells and for cellular internalization.
Quiet is leveraging this specific delivery into tumor cells to pioneer new medicines through the induction of tumor-specific immune responses or by turning cancer cells into factories that produce the agents of their own destruction.MORE ABOUT OUR TECHNOLOGY
Cohen, Z. R. et al. (2015). Localized RNAi Therapeutics of Chemoresistant Grade IV GliomaUsing Hyaluronan-Grafted Lipid-Based Nanoparticles. ACS Nano (9): 1581-1591
Quiet Therapeutics wins Wow Competition at IATI Biomed 2015 for the most innovative Pharma start-up.
Be Quiet. A great team can achieve great dreams. Making a difference is as exciting as it is rewarding.